Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Human Genome Epidemiology Literature Finder|Home|PHGKB

Human Genome Epidemiology Literature Finder


Last data update: Sep 22, 2023. (Total: 221360Documents)
   dataset        GWAS Only
Filtered By:

Previous    

Records 1 - 9 (of 9 Records)

Query Trace: Multiple Sclerosis and IRF5[original query]
Comprehensive evaluation of the genetic variants of interferon regulatory factor 5 (IRF5) reveals a novel 5 bp length polymorphism as strong risk factor for systemic lupus erythematosus.
Human molecular genetics 2008 Mar 17 (6): 872-81.
Sigurdsson Snaevar, Göring Harald H H, Kristjansdottir Gudlaug, Milani Lili, Nordmark Gunnel, Sandling Johanna K, Eloranta Maija-Leena, Feng Di, Sangster-Guity Niquiche, Gunnarsson Iva, Svenungsson Elisabet, Sturfelt Gunnar, Jönsen Andreas, Truedsson Lennart, Barnes Betsy J, Alm Gunnar, Rönnblom Lars, Syvänen Ann-Christi
Interferon regulatory factor 5 (IRF5) gene variants are associated with multiple sclerosis in three distinct populations.
Journal of medical genetics 2008 Jun 45 (6): 362-9.
Kristjansdottir G, Sandling J K, Bonetti A, Roos I M, Milani L, Wang C, Gustafsdottir S M, Sigurdsson S, Lundmark A, Tienari P J, Koivisto K, Elovaara I, Pirttilä T, Reunanen M, Peltonen L, Saarela J, Hillert J, Olsson T, Landegren U, Alcina A, Fernández O, Leyva L, Guerrero M, Lucas M, Izquierdo G, Matesanz F, Syvänen A
Validation of IRF5 as multiple sclerosis risk gene: putative role in interferon beta therapy and human herpes virus-6 infection.
Genes and immunity 2011 Jan 12 (1): 40-5.
Vandenbroeck K, Alloza I, Swaminathan B, Antigüedad A, Otaegui D, Olascoaga J, Barcina M G, de las Heras V, Bartolomé M, Fernández-Arquero M, Arroyo R, Alvarez-Lafuente R, Cénit M C, Urcelay
Interferon regulatory factor 5 gene variants and pharmacological and clinical outcome of Interferonß therapy in multiple sclerosis.
Genes and immunity 2011 Sep 12 (6): 466-72.
Vosslamber S, van der Voort L F, van den Elskamp I J, Heijmans R, Aubin C, Uitdehaag B M J, Crusius J B A, van der Pouw Kraan T C T M, van der PouwKraan T C T M, Comabella M, Montalban X, Hafler D A, De Jager P L, Killestein J, Polman C H, Verweij C
Multiple sclerosis risk genotypes correlate with an elevated cerebrospinal fluid level of the suggested prognostic marker CXCL13.
Multiple sclerosis (Houndmills, Basingstoke, England) 2013 Jun 19 (7): 863-70.
Lindén M, Khademi M, Lima Bomfim I, Piehl F, Jagodic M, Kockum I, Olsson
The influence of non-HLA gene polymorphisms and interactions on disease risk in a Western Australian multiple sclerosis cohort.
Journal of neuroimmunology 2013 Aug 261 (1-2): 92-7.
Qiu Wei, Pham Kym, James Ian, Nolan David, Castley Allison, Christiansen Frank T, Czarniak Petra, Luo Yuebei, Wu Jingshan, Garlepp Michael, Wilton Steve, Carroll William M, Mastaglia Frank L, Kermode Allan
Association between IRF5 polymorphisms and autoimmune diseases: a meta-analysis.
Genetics and molecular research : GMR 2014 13 (2): 4473-85.
Tang L, Chen B, Ma B, Nie
Prediction of response to interferon therapy in multiple sclerosis.
Acta neurologica Scandinavica 2014 Oct 130 (4): 268-75.
Sellebjerg F, Søndergaard H B, Koch-Henriksen N, Sørensen P S, Oturai A
Variants of Interferon Regulatory Factor 5 are Associated with Neither Neuromyelitis Optica Nor Multiple Sclerosis in the Southeastern Han Chinese Population.
Chinese medical journal 2015 Jul 128 (13): 1743-7.
Liu Qi-Bing, Wu Lei, Zhao Gui-Xian, Cai Ping-Ping, Li Zhen-Xin, Wu Zhi-Yi
TOP